Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to CCDC149 and LGI2 (LOC102723675)
- Target
- LOC102723675
- Molecular classification
- Other (long non-coding RNA, antisense RNA)
01
Overview
LOC102723675 is an uncharacterized human non-coding RNA gene (long non-coding RNA, or lncRNA) that is transcribed antisense to the CCDC149 and LGI2 genes. It is annotated as a novel non-coding transcript without evidence of protein-coding potential. Long non-coding antisense RNAs are often involved in regulation of gene expression by diverse mechanisms, such as modulating transcription of overlapping or neighboring sense genes, influencing local chromatin structure, or affecting RNA stability and translation. No functional studies, disease associations, or drug interactions are presently reported for this specific transcript.
- Other names
- LOC102723675ENSG00000298600Novel transcript, antisense to CCDC149 and LGI2GC04U901822GC04P024993
02
Mechanism of action
Not applicable; no drugs or therapies are known to act on this transcript
03
Biological functions
Most antisense non-coding RNAs are implicated in gene regulation, including transcriptional and post-transcriptional regulation, epigenetic modifications (such as DNA methylation and histone modification), and possible roles in chromatin remodelingSpecific function for LOC102723675 remains uncharacterized
04
Disease associations
No direct association with disease has been described for this transcriptNatural antisense transcripts in general are sometimes implicated in cancer, epigenetic dysregulation, and imprinting disorders, but no evidence connects LOC102723675 specifically to such roles
05
Safety considerations
None
06
Interacting drugs
None known
07
Biomarkers
None known
Beyond the preview
Go deeper on Novel transcript, antisense to CCDC149 and LGI2 (LOC102723675).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to CCDC149 and LGI2 (LOC102723675).